Correlation Between Atea Pharmaceuticals and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Nuvectis Pharma, you can compare the effects of market volatilities on Atea Pharmaceuticals and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Nuvectis Pharma.
Diversification Opportunities for Atea Pharmaceuticals and Nuvectis Pharma
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Atea and Nuvectis is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Atea Pharmaceuticals and Nuvectis Pharma
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the Nuvectis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Atea Pharmaceuticals is 1.72 times less risky than Nuvectis Pharma. The stock trades about -0.24 of its potential returns per unit of risk. The Nuvectis Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 661.00 in Nuvectis Pharma on November 6, 2024 and sell it today you would earn a total of 15.00 from holding Nuvectis Pharma or generate 2.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atea Pharmaceuticals vs. Nuvectis Pharma
Performance |
| Timeline |
| Atea Pharmaceuticals |
| Nuvectis Pharma |
Atea Pharmaceuticals and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atea Pharmaceuticals and Nuvectis Pharma
The main advantage of trading using opposite Atea Pharmaceuticals and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |